Okyo Pharma
OKYO
Okyo Pharma (OKYO) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $7.00 | Jul 13, 2026 |
| Piper Sandler | Initiated Coverage | Overweight | $7.00 | Feb 20, 2026 |
| B. Riley Securities | Initiated Coverage | Buy | $5.00 | Dec 8, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Sep 23, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | May 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Feb 18, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Feb 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Feb 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Oct 24, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Oct 16, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Aug 27, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Jul 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Jul 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $6.00 | Mar 22, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $4.00 | Jan 8, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Dec 5, 2023 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $4.00 | Nov 2, 2023 |
Frequently asked questions
What is the latest analyst rating on OKYO?
On Jul 13, 2026, HC Wainwright & Co. maintained Okyo Pharma at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.